Search or choose
Find the right test or package.
RAS extended profiling analysis by Next-Generation Sequencing (NGS) plays a pivotal role in understanding colorectal cancer (CRC). RAS mutations, including KRAS, NRAS, and HRAS, are known culprits in CRC, with KRAS mutations alone accounting for 40% of cases....
RAS extended profiling analysis by Next-Generation Sequencing (NGS) plays a pivotal role in understanding colorectal cancer (CRC). RAS mutations, including KRAS, NRAS, and HRAS, are known culprits in CRC, with KRAS mutations alone accounting for 40%...
RAS extended profiling analysis by Next-Generation Sequencing (NGS) plays a pivotal role in understanding colorectal cancer (CRC). RAS mutations, including KRAS, NRAS, and HRAS, are known culprits in CRC, with KRAS mutations alone accounting for 40% of cases.
The Extended RAS profiling panel targets somatic mutations in KRAS, NRAS, and BRAF genes, providing critical information for tumor development, prognostic assessment, and predicting responses to chemotherapy and targeted therapies.
Reportable mutations are m...
RAS extended profiling analysis by Next-Generation Sequencing (NGS) plays a pivotal role in understanding colorectal cancer (CRC). RAS mutations, including KRAS, NRAS, and HRAS, are known culprits in CRC, with KRAS mutations alone accounting for 40% of cases.
The Extended RAS profiling panel targets somatic mutations in KRAS, NRAS, and BRAF genes, providing critical information for tumor development, prognostic assessment, and predicting responses to chemotherapy and targeted therapies.
Reportable mutations are met...
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.